Search Results for 'cell therapy'

NUI Galway researchers are part of an exciting EU-funded project looking at how stem cells from adult fat tissue could be used to activate the regeneration of cartilage. If successful, their work could lead to effective new treatments for millions of osteoarthritis sufferers. Positive, early results indicate the treatment could become a reality for patients within the next five years.

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

Thirty-seven Fulbright Awardees were officially announced at an event on MS The World, which was sponsored by a US Fulbright alumnus, Dr Jack Pinkowski and his wife Monica Pinkowski, as part of The Gathering on July 12. Since 1957, the Fulbright Awards are given annually by the Irish and US governments and provide Irish students, scholars, and professionals with the opportunity to study, lecture, and research at top universities and institutions throughout the United States.

Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard this week.

Director of REMEDI, Professor Timothy O’Brien, is Head of Medicine at NUI Galway and a consultant endocrinologist at Galway University Hospital. REMEDI is one of Ireland’s top biomedical research institutes.